96 related articles for article (PubMed ID: 21495034)
1. Prognostic impact of nm23-H1 and PCNA expression in pathologic stage I non-small cell lung cancer.
Liu C; Liu J; Wang X; Mao W; Jiang L; Ni H; Mo M; Wang W
J Surg Oncol; 2011 Aug; 104(2):181-6. PubMed ID: 21495034
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of nm23-H1 in stage I non-small cell lung cancer: a useful marker in prediction of metastases.
Lai WW; Wu MH; Yan JJ; Chen FF
Ann Thorac Surg; 1996 Nov; 62(5):1500-4. PubMed ID: 8893591
[TBL] [Abstract][Full Text] [Related]
3. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
4. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
Tang XJ; Zhou QH; Zhang SF; Liu LX
Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of expression of nm23-H1 and focal adhesion kinase in non-small cell lung cancer.
Hsu NY; Chen CY; Hsu CP; Lin TY; Chou MC; Chiou SH; Chow KC
Oncol Rep; 2007 Jul; 18(1):81-5. PubMed ID: 17549350
[TBL] [Abstract][Full Text] [Related]
6. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K
Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I non-small cell lung cancer.
Lin Q; Li M; Shen ZY; Xiong LW; Pan XF; Gen JF; Bao GL; Sha HF; Feng JX; Ji CY; Chen M
Jpn J Clin Oncol; 2010 Jul; 40(7):670-6. PubMed ID: 20382636
[TBL] [Abstract][Full Text] [Related]
8. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of p53 and Ki-67 antigen expression in surgically treated non-small cell lung cancer: immunocytochemical detection with imprint cytology.
Maddau C; Confortini M; Bisanzi S; Janni A; Montinaro F; Paci E; Pontenani G; Rulli P; Salani A; Zappa M; Benvenuti A; Carozzi FM
Am J Clin Pathol; 2006 Mar; 125(3):425-31. PubMed ID: 16613347
[TBL] [Abstract][Full Text] [Related]
11. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.
Wang CY; Huang MS; Huang MH; Lee HC; Hsu HS
J Surg Res; 2010 Oct; 163(2):e45-50. PubMed ID: 20638687
[TBL] [Abstract][Full Text] [Related]
12. Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China.
Chen XF; Zhang HT; Qi QY; Sun MM; Tao LY
Lung Cancer; 2005 Apr; 48(1):69-76. PubMed ID: 15777972
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of PCNA expression in non-small cell lung cancer].
Dworakowska D
Pneumonol Alergol Pol; 2005; 73(3):292-6. PubMed ID: 16989169
[No Abstract] [Full Text] [Related]
14. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of erythropoietin expression and erythropoietin receptor expression on locoregional control and survival of patients irradiated for stage II/III non-small-cell lung cancer.
Rades D; Setter C; Dahl O; Schild SE; Noack F
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):499-505. PubMed ID: 20646855
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer].
Wang Y; Zhang XR; Fu J; Tan W; Zhang W
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):369-72. PubMed ID: 15312350
[TBL] [Abstract][Full Text] [Related]
17. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract.
Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH
Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597
[TBL] [Abstract][Full Text] [Related]
18. Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA.
Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Dyla T; Jankowska R
In Vivo; 2009; 23(4):519-25. PubMed ID: 19567385
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of polysialic acid expression in resected non-small cell lung cancer.
Tanaka F; Otake Y; Nakagawa T; Kawano Y; Miyahara R; Li M; Yanagihara K; Inui K; Oyanagi H; Yamada T; Nakayama J; Fujimoto I; Ikenaka K; Wada H
Cancer Res; 2001 Feb; 61(4):1666-70. PubMed ID: 11245481
[TBL] [Abstract][Full Text] [Related]
20. Expression profile of the small heat-shock protein alpha-B-crystallin in operated-on non-small-cell lung cancer patients: clinical implication.
Cherneva R; Petrov D; Georgiev O; Slavova Y; Toncheva D; Stamenova M; Trifonova N
Eur J Cardiothorac Surg; 2010 Jan; 37(1):44-50. PubMed ID: 19651521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
